Seminars in respiratory and critical care medicine最新文献

筛选
英文 中文
Pulmonary Aspergillosis in People with Cystic Fibrosis. 囊性纤维化患者的肺曲霉菌病。
IF 3.2 3区 医学
Seminars in respiratory and critical care medicine Pub Date : 2024-02-01 Epub Date: 2024-01-29 DOI: 10.1055/s-0043-1777267
C Schwarz, P N Eschenhagen, J G Mainz, T Schmidergall, H Schuette, E Romanowska
{"title":"Pulmonary Aspergillosis in People with Cystic Fibrosis.","authors":"C Schwarz, P N Eschenhagen, J G Mainz, T Schmidergall, H Schuette, E Romanowska","doi":"10.1055/s-0043-1777267","DOIUrl":"10.1055/s-0043-1777267","url":null,"abstract":"<p><p>In the last decade, fungal respiratory diseases have been increasingly investigated for their impact on the clinical course of people with cystic fibrosis (CF), with a particular focus on infections caused by <i>Aspergillus</i> spp. The most common organisms from this genus detected from respiratory cultures are <i>Aspergillus fumigatus</i> and <i>Aspergillus terreus</i>, followed by <i>Aspergillus flavus</i>, <i>Aspergillus niger</i>, and <i>Aspergillus nidulans</i>. These species have been identified to be both chronic colonizers and sources of active infection and may negatively impact lung function in people with CF. This review article discusses definitions of aspergillosis, challenges in clinical practice, and current literature available for laboratory findings, clinical diagnosis, and treatment options for pulmonary diseases caused by <i>Aspergillus</i> spp. in people with CF.</p>","PeriodicalId":21727,"journal":{"name":"Seminars in respiratory and critical care medicine","volume":"45 1","pages":"128-140"},"PeriodicalIF":3.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139576753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiological Diagnosis of Pulmonary Aspergillosis. 肺曲霉菌病的放射学诊断。
IF 3.2 3区 医学
Seminars in respiratory and critical care medicine Pub Date : 2024-02-01 Epub Date: 2024-01-29 DOI: 10.1055/s-0043-1776998
François Laurent, Ilyes Benlala, Gael Dournes
{"title":"Radiological Diagnosis of Pulmonary Aspergillosis.","authors":"François Laurent, Ilyes Benlala, Gael Dournes","doi":"10.1055/s-0043-1776998","DOIUrl":"10.1055/s-0043-1776998","url":null,"abstract":"<p><p>Imaging plays an important role in the various forms of <i>Aspergillus</i>-related pulmonary disease. Depending on the immune status of the patient, three forms are described with distinct imaging characteristics: invasive aspergillosis affecting severely immunocompromised patients, chronic pulmonary aspergillosis affecting less severely immunocompromised patients but suffering from a pre-existing structural lung disease, and allergic bronchopulmonary aspergillosis related to respiratory exposure to <i>Aspergillus</i> species in patients with asthma and cystic fibrosis. Computed tomography (CT) has been demonstrated more sensitive and specific than chest radiographs and its use has largely contributed to the diagnosis, follow-up, and evaluation of treatment in each condition. In the last few decades, CT has also been described in the specific context of cystic fibrosis. In this particular clinical setting, magnetic resonance imaging and the recent developments in artificial intelligence have shown promising results.</p>","PeriodicalId":21727,"journal":{"name":"Seminars in respiratory and critical care medicine","volume":"45 1","pages":"50-60"},"PeriodicalIF":3.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139576754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment. 急性侵袭性肺曲霉菌病:临床表现与治疗。
IF 3.2 3区 医学
Seminars in respiratory and critical care medicine Pub Date : 2024-02-01 Epub Date: 2024-01-11 DOI: 10.1055/s-0043-1777769
Jannes Heylen, Yuri Vanbiervliet, Johan Maertens, Bart Rijnders, Joost Wauters
{"title":"Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment.","authors":"Jannes Heylen, Yuri Vanbiervliet, Johan Maertens, Bart Rijnders, Joost Wauters","doi":"10.1055/s-0043-1777769","DOIUrl":"10.1055/s-0043-1777769","url":null,"abstract":"<p><p>Among all clinical manifestations of pulmonary aspergillosis, invasive pulmonary aspergillosis (IPA) is the most acute presentation. IPA is caused by <i>Aspergillus</i> hyphae invading the pulmonary tissue, causing either tracheobronchitis and/or bronchopneumonia. The degree of fungal invasion into the respiratory tissue can be seen as a spectrum, going from colonization to deep tissue penetration with angio-invasion, and largely depends on the host's immune status. Patients with prolonged, severe neutropenia and patients with graft-versus-host disease are at particularly high risk. However, IPA also occurs in other groups of immunocompromised and nonimmunocompromised patients, like solid organ transplant recipients or critically ill patients with severe viral disease. While a diagnosis of proven IPA is challenging and often warranted by safety and feasibility, physicians must rely on a combination of clinical, radiological, and mycological features to assess the likelihood for the presence of IPA. Triazoles are the first-choice regimen, and the choice of the drug should be made on an individual basis. Adjunctive therapy such as immunomodulatory treatment should also be taken into account. Despite an improving and evolving diagnostic and therapeutic armamentarium, the burden and mortality of IPA still remains high. This review aims to give a comprehensive and didactic overview of the current knowledge and best practices regarding the epidemiology, clinical presentation, diagnosis, and treatment of acute IPA.</p>","PeriodicalId":21727,"journal":{"name":"Seminars in respiratory and critical care medicine","volume":" ","pages":"69-87"},"PeriodicalIF":3.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139425458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracorporeal Life Support in Pulmonary Hypertension: Practical Aspects. 肺动脉高压的体外生命支持:实践方面。
IF 3.2 3区 医学
Seminars in respiratory and critical care medicine Pub Date : 2023-12-01 Epub Date: 2023-09-14 DOI: 10.1055/s-0043-1772752
Marius M Hoeper
{"title":"Extracorporeal Life Support in Pulmonary Hypertension: Practical Aspects.","authors":"Marius M Hoeper","doi":"10.1055/s-0043-1772752","DOIUrl":"10.1055/s-0043-1772752","url":null,"abstract":"<p><p>Extracorporeal life support (ECLS), in particular veno-arterial extracorporeal membrane oxygenation, has emerged as a potentially life-saving treatment modality in patients presenting with pulmonary hypertension and right heart failure refractory to conventional treatment. Used mainly as a bridge to lung transplantation, ECLS is also being used occasionally as a bridge to recovery in patients with treatable causes of right heart failure. This review article describes indications, contraindications, techniques, and outcomes of the use of ECLS in patients with PH, focusing on practical aspects in the management of such patients.</p>","PeriodicalId":21727,"journal":{"name":"Seminars in respiratory and critical care medicine","volume":" ","pages":"771-776"},"PeriodicalIF":3.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10246104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Pulmonary Hypertension Associated with Chronic Lung Disease. 与慢性肺病相关的肺动脉高压的治疗。
IF 3.2 3区 医学
Seminars in respiratory and critical care medicine Pub Date : 2023-12-01 Epub Date: 2023-07-24 DOI: 10.1055/s-0043-1770121
Isabel Blanco, Fernanda Hernández-González, Agustín García, Rodrigo Torres-Castro, Joan A Barberà
{"title":"Management of Pulmonary Hypertension Associated with Chronic Lung Disease.","authors":"Isabel Blanco, Fernanda Hernández-González, Agustín García, Rodrigo Torres-Castro, Joan A Barberà","doi":"10.1055/s-0043-1770121","DOIUrl":"10.1055/s-0043-1770121","url":null,"abstract":"<p><p>Pulmonary hypertension (PH) is a common complication of chronic lung diseases, particularly in chronic obstructive pulmonary disease (COPD) and interstitial lung diseases (ILD) and especially in advanced disease. It is associated with greater mortality and worse clinical course. Given the high prevalence of some respiratory disorders and because lung parenchymal abnormalities might be present in other PH groups, the appropriate diagnosis of PH associated with respiratory disease represents a clinical challenge. Patients with chronic lung disease presenting symptoms that exceed those expected by the pulmonary disease should be further evaluated by echocardiography. Confirmatory right heart catheterization is indicated in candidates to surgical treatments, suspected severe PH potentially amenable with targeted therapy, and, in general, in those conditions where the result of the hemodynamic assessment will determine treatment options. The treatment of choice for these patients who are hypoxemic is long-term oxygen therapy and pulmonary rehabilitation to improve symptoms. Lung transplant is the only curative therapy and can be considered in appropriate cases. Conventional vasodilators or drugs approved for pulmonary arterial hypertension (PAH) are not recommended in patients with mild-to-moderate PH because they may impair gas exchange and their lack of efficacy shown in randomized controlled trials. Patients with severe PH (as defined by pulmonary vascular resistance >5 Wood units) should be referred to a center with expertise in PH and lung diseases and ideally included in randomized controlled trials. Targeted PAH therapy might be considered in this subset of patients, with careful monitoring of gas exchange. In patients with ILD, inhaled treprostinil has been shown to improve functional ability and to delay clinical worsening.</p>","PeriodicalId":21727,"journal":{"name":"Seminars in respiratory and critical care medicine","volume":" ","pages":"826-839"},"PeriodicalIF":3.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9866178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Diagnostic Approach to Pulmonary Hypertension. 肺动脉高压的诊断方法。
IF 3.2 3区 医学
Seminars in respiratory and critical care medicine Pub Date : 2023-12-01 Epub Date: 2023-07-24 DOI: 10.1055/s-0043-1770116
Adam Torbicki, Marcin Kurzyna
{"title":"The Diagnostic Approach to Pulmonary Hypertension.","authors":"Adam Torbicki, Marcin Kurzyna","doi":"10.1055/s-0043-1770116","DOIUrl":"10.1055/s-0043-1770116","url":null,"abstract":"<p><p>The clinical presentation of pulmonary hypertension (PH) is nonspecific, resulting in significant delays in its detection. In the majority of cases, PH is a marker of the severity of other cardiopulmonary diseases. Differential diagnosis aimed at the early identification of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) who do require specific and complex therapies is as important as PH detection itself. Despite all efforts aimed at the noninvasive assessment of pulmonary arterial pressure, the formal confirmation of PH still requires catheterization of the right heart and pulmonary artery. The current document will give an overview of strategies aimed at the early diagnosis of PAH and CTEPH, while avoiding their overdiagnosis. It is not intended to be a replica of the recently published European Society of Cardiology (ESC) and European Respiratory Society (ERS) Guidelines on Diagnosis and Treatment of Pulmonary Hypertension, freely available at the Web sites of both societies. While promoting guidelines' recommendations, including those on new definitions of PH, we will try to bring them closer to everyday clinical practice, benefiting from our personal experience in managing patients with suspected PH.</p>","PeriodicalId":21727,"journal":{"name":"Seminars in respiratory and critical care medicine","volume":" ","pages":"728-737"},"PeriodicalIF":3.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9868174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical Emergencies in Pulmonary Hypertension. 肺动脉高压的医疗急救。
IF 3.2 3区 医学
Seminars in respiratory and critical care medicine Pub Date : 2023-12-01 Epub Date: 2023-08-18 DOI: 10.1055/s-0043-1770120
Samuel Seitler, Konstantinos Dimopoulos, Sabine Ernst, Laura C Price
{"title":"Medical Emergencies in Pulmonary Hypertension.","authors":"Samuel Seitler, Konstantinos Dimopoulos, Sabine Ernst, Laura C Price","doi":"10.1055/s-0043-1770120","DOIUrl":"10.1055/s-0043-1770120","url":null,"abstract":"<p><p>The management of acute medical emergencies in patients with pulmonary hypertension (PH) can be challenging. Patients with preexisting PH can rapidly deteriorate due to right ventricular decompensation when faced with acute physiological challenges that would usually be considered low-risk scenarios. This review considers the assessment and management of acute medical emergencies in patients with PH, encompassing both pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), acknowledging these comprise the more severe groups of PH. Management protocols are described in a systems-based approach. Respiratory emergencies include pulmonary embolism, airways disease, and pneumonia; cardiac emergencies including arrhythmia and chest pain with acute myocardial infarction are discussed, alongside PH-specific emergencies such as pulmonary artery dissection and extrinsic coronary artery compression by a dilated proximal pulmonary artery. Other emergencies including sepsis, severe gastroenteritis with dehydration, syncope, and liver failure are also considered. We propose management recommendations for medical emergencies based on available evidence, international guidelines, and expert consensus. We aim to provide advice to the specialist alongside the generalist, and emergency doctors, nurses, and acute physicians in nonspecialist centers. A multidisciplinary team approach is essential in the management of patients with PH, and communication with local and specialist PH centers is paramount. Close hemodynamic monitoring during medical emergencies in patients with preexisting PH is vital, with early referral to critical care recommended given the frequent deterioration and high mortality in this setting.</p>","PeriodicalId":21727,"journal":{"name":"Seminars in respiratory and critical care medicine","volume":" ","pages":"777-796"},"PeriodicalIF":3.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10381607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Updated Hemodynamic Definition and Classification of Pulmonary Hypertension. 肺动脉高压的最新血液动力学定义和分类。
IF 3.2 3区 医学
Seminars in respiratory and critical care medicine Pub Date : 2023-12-01 Epub Date: 2023-08-18 DOI: 10.1055/s-0043-1770115
Benoit Lechartier, Mithum Kularatne, Xavier Jaïs, Marc Humbert, David Montani
{"title":"Updated Hemodynamic Definition and Classification of Pulmonary Hypertension.","authors":"Benoit Lechartier, Mithum Kularatne, Xavier Jaïs, Marc Humbert, David Montani","doi":"10.1055/s-0043-1770115","DOIUrl":"10.1055/s-0043-1770115","url":null,"abstract":"<p><p>Pulmonary hypertension (PH) is a pathophysiological manifestation of a heterogeneous group of diseases characterized by abnormally elevated pulmonary arterial pressures diagnosed on right heart catheterization. The 2022 European Society of Cardiology (ESC) and European Respiratory Society (ERS) Guidelines for the diagnosis and treatment of PH provides a new hemodynamic definition to define PH by lowering the threshold of the mean pulmonary artery pressure (mPAP) to 20 mm Hg. Precapillary PH is thus now defined as a mPAP >20 mm Hg together with a normal pulmonary artery wedge pressure (<15 mm Hg) and an increased pulmonary vascular resistance (>2 Wood Units). The ESC/ERS 2022 Guidelines also introduce a revised clinical classification of PH while retaining its previous distinction between the five groups according to the underlying pathophysiology.</p>","PeriodicalId":21727,"journal":{"name":"Seminars in respiratory and critical care medicine","volume":" ","pages":"721-727"},"PeriodicalIF":3.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10381609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension. 肺动脉高压专题:慢性血栓栓塞性肺动脉高压的医学和介入治疗。
IF 3.2 3区 医学
Seminars in respiratory and critical care medicine Pub Date : 2023-12-01 Epub Date: 2023-08-11 DOI: 10.1055/s-0043-1770122
Marion Delcroix, Catharina Belge, Geert Maleux, Laurent Godinas
{"title":"Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension.","authors":"Marion Delcroix, Catharina Belge, Geert Maleux, Laurent Godinas","doi":"10.1055/s-0043-1770122","DOIUrl":"10.1055/s-0043-1770122","url":null,"abstract":"<p><p>Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute pulmonary embolism. The reasons why clots do not resorb are incompletely understood, but the result is partial or complete fibrothrombotic obstruction of pulmonary arteries. A secondary microvasculopathy aggravates the pulmonary hypertension (PH) as a consequence of high flow and shear stress in the nonoccluded arteries. The treatment of CTEPH has long been purely surgical, but many patients were inoperable because of inaccessible lesions or severe comorbidities. Alternatives were developed, including medical therapy and more recently balloon pulmonary angioplasty (BPA). Depending on the generation of the obstructed vessels, the treatment will be surgical, up to the (sub)segmental level, or by BPA for more distal vessels. PH drugs are used to treat the microvasculopathy. The current paper describes the therapeutic management of inoperable patients: the medical approach with PH drugs used in mono- or combination therapy; the proper use of anticoagulants in CTEPH; the technique, indications, and results at short- and long-term of BPA; the multimodal approach for inoperable patients combining PH drugs and BPA; and the effects of rehabilitation. It shows the importance of a multidisciplinary approach to the disease.</p>","PeriodicalId":21727,"journal":{"name":"Seminars in respiratory and critical care medicine","volume":" ","pages":"840-850"},"PeriodicalIF":3.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9977176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgery and Anesthesia in Patients with Pulmonary Hypertension. 肺动脉高压患者的手术和麻醉。
IF 3.2 3区 医学
Seminars in respiratory and critical care medicine Pub Date : 2023-12-01 Epub Date: 2023-09-20 DOI: 10.1055/s-0043-1772753
Robin Condliffe, Ruth Newton, Kris Bauchmuller, Tessa Bonnett, Robert Kerry, Alexa Mannings, Amanda Nair, Karen Selby, Paul P Skinner, Victoria J Wilson, David G Kiely
{"title":"Surgery and Anesthesia in Patients with Pulmonary Hypertension.","authors":"Robin Condliffe, Ruth Newton, Kris Bauchmuller, Tessa Bonnett, Robert Kerry, Alexa Mannings, Amanda Nair, Karen Selby, Paul P Skinner, Victoria J Wilson, David G Kiely","doi":"10.1055/s-0043-1772753","DOIUrl":"10.1055/s-0043-1772753","url":null,"abstract":"<p><p>Pulmonary hypertension is characterized by right ventricular impairment and a reduced ability to compensate for hemodynamic insults. Consequently, surgery can be challenging but is increasingly considered in view of available specific therapies and improved longer term survival. Optimal management requires a multidisciplinary patient-centered approach involving surgeons, anesthetists, pulmonary hypertension clinicians, and intensivists. The optimal pathway involves risk:benefit assessment for the proposed operation, optimization of pulmonary hypertension and any comorbidities, the appropriate anesthetic approach for the specific procedure and patient, and careful monitoring and management in the postoperative period. Where patients are carefully selected and meticulously managed, good outcomes can be achieved.</p>","PeriodicalId":21727,"journal":{"name":"Seminars in respiratory and critical care medicine","volume":" ","pages":"797-809"},"PeriodicalIF":3.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41139828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信